// App-Quantinova.ai

3664 : RARRES2 functions as a direct tumor suppressor by promoting beta-catenin phosphorylation and degradation independent of CMKLR1 and CMKLR1-mediated antitumor immune response in adrenocortical carcinoma

Researchers

Presenter

  • Yi Liu-Chittenden

Principal Investigators

  • Kelli Gaskins

  • Sophie Wang

  • Electron Kebebew

Medical Centers

  • National Cancer Institute, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adrenal carcinoma

  • Liver cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • Acetyl-CoA carboxylase

  • Mitogen-activated protein kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved